作者
Andreas D Haas, Elizabeth Radin, Avi J Hakim, Andreas Jahn, Neena M Philip, Sasi Jonnalagadda, Suzue Saito, Andrea Low, Hetal Patel, Amee M Schwitters, John H Rogers, Koen Frederix, Evelyn Kim, George Bello, Daniel B Williams, Bharat Parekh, Karampreet Sachathep, Danielle T Barradas, Thokozani Kalua, Sehin Birhanu, Godfrey Musuka, Owen Mugurungi, Beth A Tippett Barr, Katrina Sleeman, Lloyd B Mulenga, Kyaw Thin, Trong T Ao, Kristin Brown, Andrew C Voetsch, Jessica E Justman
发表日期
2020/11
期刊
Journal of the International AIDS Society
卷号
23
期号
11
页码范围
e25631
简介
Introduction
The global target for 2020 is that ≥90% of people living with HIV (PLHIV) receiving antiretroviral therapy (ART) will achieve viral load suppression (VLS). We examined VLS and its determinants among adults receiving ART for at least four months.
Methods
We analysed data from the population‐based HIV impact assessment (PHIA) surveys in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017). PHIA surveys are nationally representative, cross‐sectional household surveys. Data collection included structured interviews, home‐based HIV testing and laboratory testing. Blood samples from PLHIV were analysed for HIV RNA, CD4 counts and recent exposure to antiretroviral drugs (ARVs). We calculated representative estimates for the prevalence of VLS (viral load <1000 copies/mL), nonsuppressed viral load (NVL; viral load ≥1000 copies/mL), virologic failure (VF; ARVs present and viral …
引用总数